title: A review of hypertension management in Canada.
abstract: Reducing a patient's global CV risk requires a multifactorial approach. Medication is only a part of a patient's therapy. Lifestyle modifications such as diet and exercise should be encouraged. Several larger trials in hypertension have provided us with new recommendations: Statins for hypertensive patients regardless of cholesterol. ASA in patients with well-controlled hypertension. Thiazide diuretics and ARBs can be initial treatment options. Avoid the following as initial monotherapy in hypertensive patients: beta-blockers in the elderly, ACE inhibitors in black patients and alpha-adrenergic blockers. Follow-up of these largely asymptomatic patients should be performed frequently. Reasons for poor response should be investigated and additional antihypertensive therapy added, if appropriate, to achieve target blood pressures.
authors.affiliation: London Health Sciences Centre, London, Ontario. Seadna.Ledger@lhsc.on.ca
authors.forename: Séadna
authors.initials: S
authors.lastname: Ledger
mesh_terms: D002170:Canada; D003920:Diabetes Mellitus; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy*; D010349:Patient Compliance; D017410:Practice Guidelines as Topic; D012016:Reference Values; D020521:Stroke / Q000517:prevention & control
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors